文献速递精神分裂症与精神病性障碍

首发精神分裂症谱系障碍早期干预与常规治疗的20年随访:临床康复与长期关联

Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder: 20-Year Follow-up of the OPUS Trial.
PubMed 文献 · JAMA Psychiatry · 2023-01-01

丹麦多中心随机临床试验OPUS纳入547例首发精神分裂症谱系障碍患者,比较2年早期干预服务(EIS)与常规治疗(TAU)的20年长期关联。20年随访时164人(30%)接受访谈,两组在整体功能、精神病性症状、阴性症状、住院天数、门诊接触及死亡率上均无显著差异;全样本中40%达症状缓解、18%达临床康复。

要点

  • 2年EIS与TAU在20年随访时整体功能、精神病性及阴性症状维度均无显著差异。
  • 两组死亡率、10至20年住院天数及门诊接触次数亦无显著差异。
  • 全样本40%症状缓解、18%临床康复,提示需新举措维持EIS早期获益并改善远期结局。

核心结论

  • 在首发精神分裂症谱系障碍患者中,2年早期干预服务与常规治疗相比,20年随访时未观察到显著长期关联差异。
  • 需要新举措以维持2年EIS所取得的积极结局并进一步改善极长期结局。

研究设计与样本

  • 丹麦多中心随机临床试验,1998年1月至2000年12月纳入547例18至45岁首发精神分裂症谱系障碍患者,分配至OPUS早期干预组或TAU组。
  • 排除随机化前使用抗精神病药超过12周、物质所致精神病、精神残疾或器质性精神障碍者;20年随访由对原始治疗盲法的评定者完成。

主要发现

  • 20年随访时164例(30%)接受访谈,平均(SD)年龄45.9(5.6)岁,女性85例(51.8%)。
  • OPUS组死亡率13.1%(n=36),TAU组15.1%(n=41)。
  • 全样本中53例(40%)处于症状缓解,23例(18%)处于临床康复。

关键数值与推荐

  • EIS(OPUS)为2年 assertive community treatment,包括社交技能训练、心理教育和多学科团队参与的家庭介入。
  • TAU为可获得的社区精神卫生治疗。

临床怎么用

  • 对首发精神分裂症谱系障碍患者,2年EIS的短期获益未必转化为20年长期功能或症状优势,临床应持续监测并强化长期维持策略。
  • 长期随访中症状缓解与临床康复比例仍有限,提示需关注极长期康复支持。

局限性

  • 20年临床评估访谈脱落率高(仅30%受访),临床评估解释受限。
  • 登记数据无脱落,但脱落偏倚很可能强化了未观察到OPUS长期关联的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The OPUS 20-year follow-up is the longest follow-up of a randomized clinical trial testing early intervention services (EIS) among individuals with first-episode schizophrenia spectrum disorder. OBJECTIVE: To report on long-term associations of EIS compared with treatment as usual (TAU) for first-episode schizophrenia spectrum disorder. DESIGN, SETTING, AND PARTICIPANTS: A total of 547 individuals were included in this Danish multicenter randomized clinical trial between January 1998 and December 2000 and allocated to early intervention program group (OPUS) or TAU. Raters who were blinded to the original treatment performed the 20-year follow-up. A population-based sample aged 18 to 45 years with first-episode schizophrenia spectrum disorder were included. Individuals were excluded if they were treated with antipsychotics (>12 weeks prior to randomization), had substance-induced psychosis, had mental disability, or had organic mental disorders. Analysis took place between December 2021 and August 2022. INTERVENTIONS: EIS (OPUS) consisted of 2 years of assertive community treatment including social skill training, psychoeducation, and family involvement by a multidisciplinary team. TAU consisted of the available community mental health treatment. MAIN OUTCOMES AND MEASURES: Psychopathological and functional outcomes, mortality, days of psychiatric hospitalizations, number of psychiatric outpatient contacts, use of supported housing/homeless shelters, symptom remission, and clinical recovery. RESULTS: Of 547 participants, 164 (30%) were interviewed at 20-year follow-up (mean [SD] age, 45.9 [5.6] years; 85 [51.8%] female). No significant differences were found between the OPUS group compared with the TAU group on global functional levels (estimated mean difference, -3.72 [95% CI, -7.67 to 0.22]; P = .06), psychotic symptom dimensions (estimated mean difference, 0.14 [95% CI, -0.25 to 0.52]; P = .48), and negative symptom dimensions (estimated mean difference, 0.13 [95% CI, -0.18 to 0.44]; P = .41). The mortality rate was 13.1% (n = 36) in the OPUS group and 15.1% (n = 41) in the TAU group. Likewise, no differences were found 10 to 20 years after randomization between the OPUS and TAU groups on days of psychiatric hospitalizations (incidence rate ratio, 1.20 [95% CI, 0.73-1.20]; P = .46) or number of outpatient contacts (incidence rate ratio, 1.20 [95% CI, 0.89-1.61]; P = .24). Of the entire sample, 53 participants (40%) were in symptom remission and 23 (18%) were in clinical recovery. CONCLUSIONS AND RELEVANCE: In this follow-up study of a randomized clinical trial, no differences between 2 years of EIS vs TAU among individuals with diagnosed schizophrenia spectrum disorders at 20 years were found. New initiatives are needed to maintain the positive outcomes achieved after 2 years of EIS and furthermore improve very long-term outcomes. While registry data was without attrition, interpretation of clinical assessments are limited by high attrition rate. However, this attrition bias most likely confirms the lack of an observed long-term association of OPUS with outcomes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00157313.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hansen HG, Starzer M, Nilsson SF, et al. Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder: 20-Year Follow-up of the OPUS Trial. JAMA Psychiatry. 2023. PMID: 36811902. doi:10.1001/jamapsychiatry.2022.5164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。